NeuroMetrix hits record low after swinging to Q2 loss

NeuroMetrix

18/07/2019 15:30

** Shares of medical equipment maker  NURO.O  fall as much
as 22.4% to record low of 35.5 cents
    ** Company swung to Q2 loss, reported 37% decline in Q2 rev;
rev falls 28% short of IBES Refinitiv estimates   urn:newsml:reuters.com:*:nASB01TLU
    ** NURO says a charge of $2.3 mln was recorded to cover
restructuring costs
    ** Stock on course for worst session in three weeks
    ** Co has initiated process to evaluate a potential
divestiture of its DPNCheck product line; DPNCheck is a rapid
point-of-care test for diabetic neuropathy
    ** Ladenburg Thalmann & Co Inc retained to explore potential
sale or merger of company 
    ** Including session's losses, stock down ~44% so far this
year, on track for sixth straight year of losses

 (Reporting by Susan Mathew in Bengaluru;)
 ((Reuters Messaging:
susan.mathew.thomsonreuters.com@reuters.net))